Features and Specifications
Photo-Sequencing Technology (PST)
HEALITE II employs a unique approach to phototherapy which is termed ‘photo-sequencing’. Photo-sequencing involves the delivery of pre-conditioning low doses of 590 nm energy to the superficial skin in micro-low level light therapy (µ-LLLT), in combination with powerful but gentle deep-penetrating near-infrared (near-IR) light at 830 nm.
Sequencing Function of 590 nm µ-LLLT and 830 nm?
• Precondition the epidermal cells, especially the keratinocytes, to start to manufacture cytokines.
Diagrammatic representation of the components of typical female facial skin, with approximate depth markers illustrating the relative penetration and therefore absorption depths of 590 nm and 830 nm, the two wavelengths comprising the HeaLite II photosequencing technology. |
Superior Phototherapy System
HEALITE II 830 nm energy offers a superior phototherapeutic effect due to the clinically useful photon intensity and deep penetration at this wavelength, coupled with the 590 nm µ-LLLT preconditioning photosequencing technology. With this approach, all the relevant cells in the epidermis and dermis are photoactivated to facilitate the therapeutic goal, whether it is enhancing the skin regeneration process, healing of bone fractures or alleviation of pain.
Safe & Simple operation
Recommended Procedure
Optic Lens Array Technology (OLAT)
HEALITE II’s Optic Lens Array Technology prevents dispersion of light energy from each LED, ensuring delivery of concentrated light energy into treatment area without unnecessary loss.
LEDs in an array fitted with OLAT to limit beam divergenceTypical emission pattern of HeaLite II 830 nm LEDs with divergence limited by OLAT. Precise positioning of the LEDs in the array panel causes multiple intersection of the LED beams, resulting in the photon interference phenomenon. This, in conjunction with the high scattering coefficient of light at 830 nm, generates the zone with the highest photon intensity below the target skin surface in the dermis, where the main target cells for phototherapy exist.
|
Wound healing after elective incisional surgery and full-face ablative resurfacing, with and without 830 nm LED phototherapy
Source: Trelles MA & Calderhead RG: 830 nm LED phototherapy significantly shortens the healing time and ameliorates sequelae after elective incisional surgery: a controlled study. Laser Therapy (2011) (Accepted and waiting publication)
830 nm: Raises the action potential of the cells essential for the wound healing process
Mast, mast cells; Neutro, neutrophils; Macro, macrophages; Fibro, fibroblasts;
Fibro-Myo, fibroblast to myofibroblast transformation; Keratino, keratinocytes.
Level of action potential: +++, very high; ++, high; +, some; ±, little or none; – , retardation;
*, in vitro studies; †, in vivo studis; ?, unknown.
Wavelength
830 nm + 590 nm µ-LLLT
Operation Time
10 min at 100 mW/cm²
LED Treatment Area
180 mm x 400 mm (1,800 LEDs)
Treatment Mode
• Photo-Sequencing Technology (PST)
• Photon Absorption Therapy (PAT)
User Interface
LCD Touch Screen
Power Requirements
AC110, 220 V / 60 Hz
Other Features
• Heat Control System
• Safety Functions (Option)
• Ergonomic Self-Stay Arm and Array Hinges
• Optic Lens Array Technology (OLAT)
Body Dimension(mm)
556 (W) X 671 (L) X 1562 (H)
Head Dimension(mm)
510 (W) X 300 (L) X 110 (H)
Weight
27Kg